Management of diabetes in pregnancy: Challenges and trends

Canadian Journal of Diabetes

Volumn 29, Issue 3, 2005, Pages 246-256

  Meltzer, Sara J ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Gestational diabetes mellitus; Insulin adjustment; Pregnancy

Indexed keywords

GLIBENCLAMIDE; METFORMIN;

BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; DELIVERY; DIABETES MELLITUS; EXERCISE; FETOPLACENTAL UNIT; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HEALTH CARE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; MACROSOMIA; MATERNAL CARE; MATERNAL NUTRITION; MORBIDITY; MORTALITY; PATIENT CARE; PLACENTAL TRANSFER; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY DIABETES MELLITUS; RETINOPATHY; REVIEW; RISK ASSESSMENT; SCREENING; SELF MONITORING;

EID: 33646682868     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2003;27:S1-S152.
2. Evers IM, de Valk HW, Mol BW, et al. Macrosomia despite good glycemic control in type 1 diabetic pregnancy; results of a nationwide study in the Netherlands. Diabetologia. 2002;45:1484-1489.
3. Hadden DR, Alexander A, McCance DR, et al. Obstetric and diabetic care for pregnancy in diabetic women: 10 years outcome analysis, 1985-1995. Diabet Med. 2001;18:546-553.
4. Jensen DM, Damm P, Moelsted-Pedersen L, et al. Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care. 2004;27:2819-2823.
5. Persson B, Hanson U. Neonatal morbidities in gestational diabetes mellitus. Diabetes Care. 1998;21(suppl 2):B79-B84.
6. Quevedo ST, Coustan DR. Diabetes and pregnancy. Use of an integrated "team" approach provides the necessary comprehensive care. R I Med J. 1989;72:129-132.
7. Freinkel N. Banting Lecture 1980. Of pregnancy and progeny. Diabetes. 1980;29:1023-1035.
8. Butte NF. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr. 2000;71(suppl 5):1256S-1261S.
9. Catalano PM, Drago NM, Amini SB. Longitudinal changes in pancreatic beta-cell function and metabolic clearance rate of insulin in pregnant women with normal and abnormal glucose tolerance. Diabetes Care. 1998;21:403-408.
10. Rosenn BM, Miodovnik M, Holcberg G, et al. Hypoglycemia: the price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus. Obstet Gynecol. 1995;85:417-422.
11. Rosenn BM, Miodovnik M, Khoury JC, et al. Deficient counterregulation: a possible risk factor for excessive fetal growth in IDDM pregnancies. Diabetes Care. 1997;20:872-874.
12. Fowden AL, Hill DJ. Intra-uterine programming of the endocrine pancreas. Br Med Bull. 2001;60:123-142.
13. Butte NF, Wong WW, Treuth MS, et al. Energy requirements during pregnancy based on total energy expenditure and energy deposition. Am J Clin Nutr. 2004;79:1078-1087.
14. Subcommittee on Nutritional Status and Weight Gain During Pregnancy, Institute of Medicine. Nutrition During Pregnancy. Washington, DC: National Academy Press; 1990.
15. Jovanovic L. Time to reassess the optimal dietary prescription for women with gestational diabetes [editorial]. Am J Clin Nutr. 1999;70:3-4.
16. Jovanovic L. Medical nutrition therapy in pregnant women with pregestational diabetes mellitus. J Matern Fetal Med. 2000;9:21-28.
17. Gillmer MD, Beard, RW, Brooke FM, et al. Carbohydrate metabolism in pregnancy. Part I. Diurnal plasma glucose profile in normal and diabetic women. Br Med J. 1975;3:399-404.
18. Meltzer S, Snyder J, Nudi M, et al. Randomized clinical trial of CDA-recommended 75 g and 100 g OGTT to evaluate prevalence of GDM and IGT in pregnancy [abstract]. Can J Diabetes. 2004;28(suppl 1):314. Abstract 249.
19. Fuhrmann K, Reiher H, Semmler K, et al. Prevention of congenital malformations in infants of insulin-dependent diabetic mothers. Diabetes Care. 1983;6:219-223.
20. Miller E, Hare JW, Cloherty JP, et al. Elevated maternal hemoglobin A1C in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med. 1981;304:1331-1334.
21. Ray JG, O'Brian TE, Chan WS. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. QJM. 2001;94:435-444.
22. Suhonen L, Hiilesmaa V, Teramo K. Glycaemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus. Diabetologia. 2000;43:79-82.
23. Combs CA, Gunderson E, Kitzmiller JL, et al. Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy. Diabetes Care. 1992;15:1251-1257.
24. de Veciana M, Major CA, Morgan MA, et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med. 1995;333:1237-1241.
25. Jovanovic-Peterson L, Peterson CM, Reed GF, et al. Maternal postprandial glucose levels and infant birth weight: The Diabetes in Early Pregnancy Study. Am J Obstet Gynecol. 1991;164:103-111.
26. Lauenborg J, Hansen T, Jensen DM et al. Increasing Incidence of diabetes after gestational diabetes: a long-term follow-up in a Danish population. Diabetes Care. 2004;27:1194-1199.
27. Colditz GA, Willett WC, Rotnitzky A, et al. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995;122:481-486.
28. Choi BC, Shi F. Risk factors for diabetes mellitus by age and sex: results of the National Population Health Survey. Diabetologia. 2001;44:1221-1231.
29. Meltzer S, Leiter L, Daneman D, et al. 1998 clinical practice guidelines for the management of diabetes in Canada. CMAJ. 1998;159(suppl 8):S1-S29.
30. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039-1057.
31. Lemieux L, Ryan EA. The need for insulin in subjects with impaired glucose tolerance of pregnancy. Can J Diabetes. 2004;28:196-200.
32. Ryan EA, Mereu L. Diabetes management during pregnancy. In: Gerstein HC, Haynes RB, eds. Evidence-Based Diabetes Care. Hamilton, ON: BC Decker; 1999:344-369.
33. 1c levels are significantly lower in early and late pregnancy. Diabetes Care. 2004;27:1200-1201.
34. McElvy SS, Miodovnik M, Rosenn B, et al. A focused preconceptional and early pregnancy program in women with type 1 diabetes reduces perinatal mortality and malformation rates to general population levels. J Matern Fetal Med. 2000;9:14-20.
35. Nachum Z, Ben Shlomo I, Weiner E, et al. Twice daily versus four times daily insulin dose regimens for diabetes in pregnancy: a randomised controlled trial. BMJ. 1999;319:1223-1227.
36. Van Allen MI, McCourt C, Lee NS. Preconception Health: Folic Acid for the Primary Prevention of Neural Tube Defects. A Resource Document for Health Professionals. Ottawa, ON: Minister of Public Works and Government Services Canada; 2002. Publication No. H39-607/2002E.
37. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
38. The Diabetes Control and Complications Trial Research Group. Effect of pregnancy on microvascular complications in the Diabetes Control and Complications Trial. Diabetes Care. 2000;23:1084-1091.
39. Klein BE, Moss SE, Klein R. Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care. 1990;13:34-40.
40. Omori Y, Minei S, Testuo T, et al. Current status of pregnancy in diabetic women: A comparison of pregnancy in IDDM and NIDDM mothers. Diabetes Res Clin Pract. 1994;24(suppl):S273-S278.
41. Chew EY, Mills JL, Metzger BE, et al. Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study. Diabetes Care. 1995;18:631-637.
42. The Diabetes Control and Complications Trial Research Group. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthamol. 1998;116:874-886.
43. Lovestam-Adrian M, Agardh CD, Aberg A, et al. Pre-eclampsia is a potent risk factor for deterioration of retinopathy during pregnancy in type 1 diabetic patients. Diabet Med. 1997;14:1059-1065.
44. Rosenn B, Miodovnik M, Kranias G, et al. Progression of diabetic retinopathy in pregnancy: association with hypertension in pregnancy. Am J Obstet Gynecol. 1992;166:1214-1218.
45. Biesenbach G, Grafinger P, Stoger H, et al. How pregnancy influences renal function in nephropathic type 1 diabetic women depends on their pre-conceptional creatinine clearance. J Nephrol. 1999;12:41-46.
46. Kitzmiller JL, Combs CA. Management and outcome of pregnancies complicated by diabetic nephropathy. In: Dornhorst A, Haddon DR, eds. Diabetes and Pregnancy: An International Approach to Diagnosis and Management. Toronto, ON: John Wiley & Sons Ltd.; 1996:167-206.
47. Hiilesmaa V, Suhonen L, Teramo K. Glycaemic control is associated with pre-eclampsia but not with pregnancy-induced hypertension in women with type 1 diabetes mellitus. Diabetologia. 2000;43:1534-1539.
48. Reece EA, Leguizamon G, Homko C. Stringent controls in diabetic nephropathy associated with optimization of pregnancy outcomes. J Matern Fetal Med. 1998;7:213-216.
49. Magee L. Drugs in pregnancy. Antihypertensives. Best Pract Res Clin Obstet Gynaecol. 2001;15:827-845.
50. Bagg W, Henley PG, Macpherson P, et al. Pregnancy in women with diabetes and ischaemic heart disease. Aust N Z J Obstet Gynecol. 1999;39:99-102.
51. Jovanovic L. Achieving euglycaemia in women with gestational diabetes mellitus: current options for screening, diagnosis and treatment. Drugs. 2004;64:1401-1417.
52. Churchill JA, Berendes HW, Nemore J. Neuropsychological deficits in children of diabetic mothers. A report from the Collaborative Study of Cerebral Palsy. Am J Obstet Gynecol. 1969;105:257-268.
53. Rizzo T, Metzger BE, Burns WJ, et al. Correlations between antepartum maternal metabolism and child intelligence. N Engl J Med. 1991;325:911-916.
54. Gabbe SG, Holing E, Temple P, et al. Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus. Am J Obstet Gynecol. 2000;182:1283-1291.
55. Egger M, Davey-Smith G, Stettler C, et al. Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus; a meta-analysis. Diabet Med. 1997;14:919-928.
56. Reece EA, Hagay Z, Roberts AB, et al. Fetal doppler and behavioral responses during hypoglycemia induced with the insulin clamp technique in pregnant diabetic women. Am J Obstet Gynecol. 1995;172:151-155.
57. Kalergis M, Pacaud D, Strychar I, et al. Optimizing insulin delivery: Assessment of three strategies in intensive diabetes management. Diabetes Obes Metab. 2000;2:299-305.
58. Langer O, Anyaegbunam A, Brustman L, et al. Pregestational diabetes: insulin requirements throughout pregnancy. Am J Obstet Gynecol. 1988;159:616-621.
59. Buchanan TA, Kjos SL, Montoro MN, et al. Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care. 1994;17:275-283.
60. Rossi G, Somigliana E, Moshetta M, et al. Adequate timing of fetal ultrasound to guide metabolic therapy in mild gestational diabetes mellitus. Results from a randomized study. Acta Obstet Gynecol Scand. 2000;79:649-654.
61. Schaefer-Graf UM, Kjos SL, Kilavuz O, et al. Determinants of fetal growth at different periods of pregnancies complicated by gestational diabetes mellitus or impaired glucose tolerance. Diabetes Care. 2003;26:193-198.
62. Anderson EJ, Richardson M, Castle G, et al. Nutrition interventions for intensive therapy in the Diabetes Control and Complications Trial. J Am Diet Assoc. 1993;93:768-772.
63. Jovanovic L, Ilic S, Pettitt DJ, et al. Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care. 1999;22:1422-1427.
64. Dolci M, Mori M, Baccetti F. Use of glargine insulin before and during pregnancy in a woman with type 1 diabetes and Addison's disease [letter] Diabetes Care. 2005;28:2084-2085.
65. Glueck CJ, Wang P, Goldenberg N, et al. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod. 2002;17:2858-2864.
66. Jakubowicz DJ, Iuorno MJ, Jakubowicz S, et al. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87:524-529.
67. Simmons D, Walters BN, Rowan JA, et al. Metformin therapy and diabetes in pregnancy. Med J Aust. 2004;180:462-464.
68. Glueck CJ, Wang P, Kobayashi S, et al. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril. 2002;77:520-525.
69. Hellmuth E, Damm P, Molsted-Pedersen L. Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabet Med. 2000;17:507-511.
70. Glueck CJ, Bornovali S, Pranikoff J, et al. Metformin, preeclampsia, and pregnancy outcomes in women with polycystic ovary syndrome. Diabet Med. 2004;21:829-836.
71. Langer O, Conway DL, Berkus MD, et al. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med. 2000;343:1134-1138.
72. Tran ND, Hunter SK, Yankowitz JM. Oral hypoglycemic agents in pregnancy. Obstet Gynecol Surv. 2004;59:456-463.
73. Landon MB, Gabbe SG. Fetal surveillance and timing of delivery in pregnancy complicated by diabetes mellitus. Obstet Gynecol Clin North Am. 1996;23:109-123.
74. American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin. Clinical practice guidelines for gynecologists. Number 30, September 2001. Gestational diabetes. Obstet Gynecol. 2001;98:525-538.
75. ACOG practice bulletin. Antepartum fetal surveillance. Number 9, October 1999 (replaces Technical Bulletin Number 188, January 1994). Clinical management guidelines for obstetrician-gynecologists. Int J Gynaecol Obstet. 2000;68:175-185.
76. Moore TR. A comparison of amniotic fluid fetal pulmonary phospholipids in normal and diabetic pregnancy. Am J Obstet Gynecol. 2002;186:641-650.
77. Diabetes care and research in Europe: The Saint Vincent declaration. Diabetic Med. 1990;7:360.
78. Boulot F, Chabbert-Buffet N, d'Ercole C, et al. French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care. 2003;26:2990-2993.
79. Penney GC, Mair G, Pearson DW. Outcomes of pregnancies in women with type1 diabetes in Scotland: a national population-based study. BJOG. 2003;110:315-318.
80. Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ. 2004;328:915-920.
81. Cundy T, Gamble G, Townsend K, et al. Perinatal mortality in type 2 diabetes mellitus. Diabet Med. 2000;17:33-39.
82. Feig DS, Palda VA. Type 2 diabetes in pregnancy: a growing concern. Lancet. 2002;359:1690-1692.
83. Feig DS, Kopp A, Anderson GM. Pregnancy in women with diabetes. In: Hux JE, Booth GL, Slaughter PM, et al, eds. Diabetes in Ontario. An ICES Practice Atlas. Toronto, ON: Institute for Clinical Evaluative Sciences; 2003:4.77-4.94. Available at: http://www.ices.on.ca. Accessed August 15, 2005.
84. Svare JA, Hansen BB, Molsted-Pedersen L. Perinatal complications in women with gestational diabetes mellitus. Acta Obstet Gynecol Scand. 2001;80:899-904.
85. Crowther CA, Hiller JE, Moss JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352:2477-2486.
86. Cundy T, Slee F, Gamble G, et al. Hypertensive disorders of pregnancy in women with type 1 and type 2 diabetes. Diabet Med. 2002;19:482-489.
87. Gestation and Diabetes in France Study Group. Multicenter survey of diabetic pregnancy in France. Diabetes Care. 1991;14:994-1000.
88. Schaefer-Graf UM, Buchanan TA, Xiang A, et al. Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes. Am J Obstet Gynecol. 2000;182:313-320.
89. Silverman BL, Rizzo TA, Cho NH, et al. Long-term effects of the intrauterine environment. The Northwestern University Diabetes in Pregnancy Center. Diabetes Care. 1998;21 (suppl 2):B142-B149.
90. Moore TR. Fetal growth in diabetic pregnancy. Clin Obstet Gynecol. 1997;40:771-786.
91. Pettitt DJ, Aleck KA, Baird HR, et al. Congenital susceptibility to NIDDM. Role of intrauterine environment. Diabetes. 1988;37:622-628.
92. Plagemann A, Harder T, Kohlhoff R, et al. Glucose tolerance and insulin secretion in children of mothers with pregestational IDDM or gestational diabetes. Diabetologia. 1997;40:1094-1100.